Anzeige
Mehr »
Login
Freitag, 04.04.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
Ist das der Durchbruch für den KI-Biotech-Geheimtipp?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40DLB | ISIN: US81256L2034 | Ticker-Symbol:
NASDAQ
04.04.25
21:40 Uhr
1,370 US-Dollar
-0,005
-0,36 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SEASTAR MEDICAL HOLDING CORPORATION Chart 1 Jahr
5-Tage-Chart
SEASTAR MEDICAL HOLDING CORPORATION 5-Tage-Chart

Aktuelle News zur SEASTAR MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
28.03.SeaStar Medical Holding Corp - 8-K, Current Report1
27.03.SeaStar Medical Holding Corp - 10-K, Annual Report1
27.03.SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates126DENVER, March 27, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing...
► Artikel lesen
24.03.SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 20251
21.03.SeaStar Medical Holding Corp - 8-K, Current Report2
13.03.SeaStar Medical Holding Corp - 8-K, Current Report-
03.02.SeaStar Medical Holding Corporation: SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market1
31.01.SeaStar Medical Holding Corp - 8-K, Current Report1
SEASTAR MEDICAL Aktie jetzt für 0€ handeln
31.01.SeaStar Medical announces $6M registered direct offering priced ATM4
31.01.SeaStar Medical secures $6 million in direct offering2
22.01.SeaStar Shares Static Ahead of Drug Trials1
22.01.SeaStar Medical Holding Corporation: SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial3
13.01.SeaStar Medical Holding Corporation: FDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome107Study to be conducted under $3.6 million NIH grant DENVER, Jan. 13, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing...
► Artikel lesen
13.01.SeaStar Medical Holding Corp - 8-K, Current Report-
08.01.SeaStar Medical Holding Corporation: SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer1
26.12.24SeaStar Medical Holding Corp - 8-K, Current Report1
23.12.24SeaStar Medical Holding Corporation: SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial2
19.12.24SeaStar Medical Holding Corp - 8-K, Current Report-
11.12.24SeaStar Medical Holding Corporation: SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications8
03.12.24SeaStar Medical Holding Corporation: SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial1
Seite:  Weiter >>
52 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1